Pro-Con Debate: Opioids and Perioperative Organ Injury—Friend or Foe?

Authors: Tiongco AF et al.

Anesthesia & Analgesia, 2026 (Pro–Con Debate Section)

This article presents a structured debate on whether opioids act as protective agents against perioperative organ injury or whether they contribute to harm. The “pro” argument emphasizes a substantial body of preclinical evidence demonstrating that opioids—particularly through δ- and κ-opioid receptor activation—can reduce ischemia-reperfusion injury in organs such as the heart, kidneys, liver, and brain. Mechanistically, these effects are mediated through pathways including PI3K/AKT, MAPK, mitochondrial potassium channels, and HIF-1α signaling. In cardiac models, opioids such as morphine and methadone consistently reduce infarct size, although clinical translation is inconsistent and appears drug-specific, with morphine demonstrating more favorable functional outcomes than fentanyl. Renal and hepatic protection is also supported by animal data, with opioids reducing injury markers and promoting cellular survival pathways, though mechanisms remain incompletely understood. Neuroprotection is less consistent, with conflicting receptor-specific effects and limited human data.

In contrast, the “con” argument highlights substantial clinical and translational evidence that opioids contribute to perioperative organ injury. Within the central nervous system, opioids are associated with neuroinflammation and an increased risk of delirium, with dose-dependent effects observed in both hospital and palliative care populations. Opioid-induced hyperalgesia, particularly associated with remifentanil, leads to increased postoperative pain and opioid requirements. Additionally, opioids exert immunosuppressive effects by altering gene expression, suppressing natural killer cell activity, and increasing proinflammatory cytokines such as IL-6, which may have implications in oncologic outcomes. Gastrointestinal dysfunction, including decreased motility and opioid-induced bowel dysfunction, is well established and does not demonstrate the same tolerance seen in central nervous system pathways. Furthermore, opioids may contribute to renal injury through sympathetic activation, vasoconstriction, and indirect effects on hormonal systems, with human studies demonstrating associations with acute kidney injury.

The discussion acknowledges agreement between both perspectives that opioids have significant biologic effects beyond analgesia and may reduce ischemia-reperfusion injury under certain conditions. However, key differences lie in the consistency and clinical relevance of these effects. While preclinical data strongly support organ-protective mechanisms, human studies yield variable and often conflicting results, likely due to differences in patient populations, dosing strategies, receptor expression, and clinical context. The translational gap between experimental and clinical findings remains a major limitation.

Overall, the article concludes that opioids exert complex, system-wide effects that can be either protective or harmful depending on the clinical scenario, drug selection, and patient-specific factors. Given the inconsistent evidence for organ protection in humans and the well-documented risks—including delirium, hyperalgesia, immunosuppression, gastrointestinal dysfunction, and renal injury—it is difficult to justify opioid use specifically for the purpose of organ protection. Future research should focus on developing more selective, tissue-specific opioid receptor ligands and personalized administration strategies to maximize potential benefits while minimizing harm.

What You Should Know
Opioids are not simply analgesics—they have widespread physiologic effects that can influence multiple organ systems. While experimental models suggest potential protective effects against ischemia-reperfusion injury, clinical evidence is inconsistent and often outweighed by known adverse effects. Modern anesthesia practice should focus on thoughtful, selective opioid use within multimodal strategies rather than relying on opioids for organ protection.

Thank you to Anesthesia & Analgesia for allowing us to summarize and share the insights from this article.

Leave a Reply

Your email address will not be published. Required fields are marked *